Methylphenidate Treatment of Attention Deficits in Epilepsy
NCT02178995
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Epilepsy
Cognitive Deficits
Attention Deficits
Interventions
DRUG:
Methylphenidate
Sponsor
Kimford Jay Meador